secwatch.observer — SEC 8-K summary
======================================

Issuer:     WINDTREE THERAPEUTICS INC /DE/ (WINT)
CIK:        0000946486
Form:       8-K
Filed at:   2026-07-21T21:50:13+00:00
Accession:  0001437749-26-024009
Event type: m_and_a
Sentiment:  negative
Materiality: 0.85
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Windtree sells cardiovascular drug candidates to Seismic for $150K upfront plus contingent payments
--------------------------------------------------------------------------------

- Windtree receives $150,000 upfront for its cardiovascular drug candidates, including acute heart failure program.
- Windtree is entitled to 20% of future licensing revenue and global commercial net revenue if approved.
- If Seismic raises at least $10M, Windtree receives an additional $700,000 payment.
- Windtree transfers certain development payables to Seismic as part of the agreement.
- The deal includes transfer of intellectual property and the Taiwanese subsidiary to Seismic.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/946486/000143774926024009/0001437749-26-024009-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/946486/000143774926024009/wint20260721_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-024009

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer